Geovax Labs Inc (GOVX)
3.31
+0.03
(+0.91%)
USD |
NASDAQ |
Jul 02, 16:00
3.29
-0.02
(-0.60%)
Pre-Market: 08:33
Geovax Labs Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.0189M |
| September 30, 2023 | -0.0062M |
| June 30, 2023 | -0.0238M |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.0519M |
| June 30, 2022 | -0.0202M |
| March 31, 2022 | -0.0622M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.0278M |
| June 30, 2021 | -0.0199M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.1543M |
| September 30, 2020 | -0.0025M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.0033M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | -0.0043M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | -0.0043M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | -0.0158M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.0243M |
| June 30, 2014 | -0.0112M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | -0.00 |
| September 30, 2013 | -0.0866M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | -0.0119M |
| September 30, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.1543M
Minimum
Dec 2020
--
Maximum
Sep 2019
-0.023M
Average
-0.0062M
Median
Sep 2023
Cash from Investing (Quarterly) Benchmarks
| Merck & Co Inc | -1.376B |
| Pfizer Inc | 1.732B |
| Processa Pharmaceuticals Inc | -- |
| Biomea Fusion Inc | -0.035M |
| Moderna Inc | 118.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.684M |
| Free Cash Flow | -27.09M |
| Free Cash Flow Per Share (Quarterly) | -2.401 |
| Free Cash Flow Yield | -415.5% |